Analyst Ratings for Hemab Therapeutics Holdings (COAG)
COAG Rating Summary
COAG Price Target Summary
- Highest: $42.00 (Wedbush)
- Lowest: $36.00 (Goldman Sachs)
- Average: $39.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$39.25 (+34.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/17/2026 | H.C. Wainwright | Emily Bodnar | New Coverage | Buy (N/A) |
40.00 (N/A) |
25.51 (29.24) |
14.62% | Details |
| 5/26/2026 | Evercore ISI | Cory K | New Coverage | Outperform (N/A) |
N/A (N/A) |
25.89 (29.24) |
12.94% | Details |
 |
||||||||
|
||||||||
|
||||||||
